Generation of GGTA1-/-β2M-/-CIITA-/- Pigs Using CRISPR/Cas9 Technology to Alleviate Xenogeneic Immune Reactions
- PMID: 32732833
- DOI: 10.1097/TP.0000000000003205
Generation of GGTA1-/-β2M-/-CIITA-/- Pigs Using CRISPR/Cas9 Technology to Alleviate Xenogeneic Immune Reactions
Abstract
Background: Xenogeneic organ transplantation has been proposed as a potential approach to fundamentally solve organ shortage problem. Xenogeneic immune responses across species is one of the major obstacles for clinic application of xeno-organ transplantation. The generation of glycoprotein galactosyltransferase α 1, 3 (GGTA1) knockout pigs has greatly contributed to the reduction of hyperacute xenograft rejection. However, severe xenograft rejection can still be induced by xenoimmune responses to the porcine major histocompatibility complex antigens swine leukocyte antigen class I and class II.
Methods: We simultaneously depleted GGTA1, β2-microglobulin (β2M), and major histocompatibility complex class II transactivator (CIITA) genes using clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins technology in Bamma pig fibroblast cells, which were further used to generate GGTA1β2MCIITA triple knockout (GBC-3KO) pigs by nuclear transfer.
Results: The genotype of GBC-3KO pigs was confirmed by polymerase chain reaction and Sanger sequencing, and the loss of expression of α-1,3-galactose, SLA-I, and SLA-II was demonstrated by flow cytometric analysis using fluorescent-conjugated lectin from bandeiraea simplicifolia, anti-β2-microglobulin, and swine leukocyte antigen class II DR antibodies. Furthermore, mixed lymphocyte reaction assay revealed that peripheral blood mononuclear cells from GBC-3KO pigs were significantly less effective than (WT) pig peripheral blood mononuclear cells in inducing human CD3CD4 and CD3CD8 T-cell activation and proliferation. In addition, GBC-3KO pig skin grafts showed a significantly prolonged survival in immunocompetent C57BL/6 mice, when compared with wild-type pig skin grafts.
Conclusions: Taken together, these results demonstrate that elimination of GGTA1, β2M, and CIITA genes in pigs can effectively alleviate xenogeneic immune responses and prolong pig organ survival in xenogenesis. We believe that this work will facilitate future research in xenotransplantation.
Similar articles
-
Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses.Sci Rep. 2021 Jun 23;11(1):13131. doi: 10.1038/s41598-021-92543-y. Sci Rep. 2021. PMID: 34162938 Free PMC article.
-
Silencing the porcine iGb3s gene does not affect Galα3Gal levels or measures of anticipated pig-to-human and pig-to-primate acute rejection.Xenotransplantation. 2016 Mar;23(2):106-16. doi: 10.1111/xen.12217. Epub 2016 Jan 11. Xenotransplantation. 2016. PMID: 27106872
-
Viable pigs after simultaneous inactivation of porcine MHC class I and three xenoreactive antigen genes GGTA1, CMAH and B4GALNT2.Xenotransplantation. 2020 Jan;27(1):e12560. doi: 10.1111/xen.12560. Epub 2019 Oct 8. Xenotransplantation. 2020. PMID: 31591751
-
Modifying the sugar icing on the transplantation cake.Glycobiology. 2016 Jun;26(6):571-81. doi: 10.1093/glycob/cww028. Epub 2016 Mar 1. Glycobiology. 2016. PMID: 26935763 Free PMC article. Review.
-
B4GALNT2 and xenotransplantation: A newly appreciated xenogeneic antigen.Xenotransplantation. 2018 Sep;25(5):e12394. doi: 10.1111/xen.12394. Epub 2018 Mar 31. Xenotransplantation. 2018. PMID: 29604134 Free PMC article. Review.
Cited by
-
Expression of viral CD45 ligand E3/49K on porcine cells reduces human anti-pig immune responses.Sci Rep. 2023 Oct 11;13(1):17218. doi: 10.1038/s41598-023-44316-y. Sci Rep. 2023. PMID: 37821577 Free PMC article.
-
Xenorecognition and costimulation of porcine endothelium-derived extracellular vesicles in initiating human porcine-specific T cell immune responses.Am J Transplant. 2023 Jul;23(7):904-919. doi: 10.1016/j.ajt.2023.04.006. Epub 2023 Apr 11. Am J Transplant. 2023. PMID: 37054891
-
Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine.Biomater Res. 2023 Feb 9;27(1):10. doi: 10.1186/s40824-023-00348-z. Biomater Res. 2023. PMID: 36759929 Free PMC article. Review.
-
Genetic engineering of pigs for xenotransplantation to overcome immune rejection and physiological incompatibilities: The first clinical steps.Front Immunol. 2022 Dec 6;13:1031185. doi: 10.3389/fimmu.2022.1031185. eCollection 2022. Front Immunol. 2022. PMID: 36561750 Free PMC article. Review.
-
Cardiac xenotransplantation: from concept to clinic.Cardiovasc Res. 2023 Feb 3;118(18):3499-3516. doi: 10.1093/cvr/cvac180. Cardiovasc Res. 2023. PMID: 36461918 Free PMC article. Review.
References
-
- Bernhardt AM, Reichenspurner H. High-risk donors: extending our criteria in times of organ shortage. Curr Opin Organ Transplant. 2014; 19:494–499doi:10.1097/MOT.0000000000000118 - DOI
-
- Ekser B, Li P, Cooper DKC. Xenotransplantation: past, present, and future. Curr Opin Organ Transplant. 2017; 22:513–521doi:10.1097/MOT.0000000000000463 - DOI
-
- Cooper DKC, Pierson RN 3rd, Hering BJ, et al. Regulation of clinical xenotransplantation-time for a reappraisal. Transplantation. 2017; 101:1766–1769doi:10.1097/TP.0000000000001683 - DOI
-
- Cooper DK, Dou KF, Tao KS, et al. Pig liver xenotransplantation: a review of progress toward the clinic. Transplantation. 2016; 100:2039–2047doi:10.1097/TP.0000000000001319 - DOI
-
- Yamamoto T, Hara H, Foote J, et al. Life-supporting kidney xenotransplantation from genetically engineered pigs in baboons: a comparison of two immunosuppressive regimens. Transplantation. 2019; 103:2090–2104doi:10.1097/TP.0000000000002796 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
